Steven G. Palyca

Steven G. Palyca

Senior Associate
New York

Email steven.palyca@​

Phone +1 212 918 3234

Fax +1 212 918 3100

Practice groupCorporate

Steven Palyca advises clients on corporate and business matters, with a particular emphasis on mergers and acquisitions, joint ventures, corporate governance, private equity transactions, and licensing matters.

Steven has worked with clients in both the U.S. and international markets, advising on complex corporate reorganization and governance matters. He has represented both buyers and sellers in acquisitions across a number of industries, including media, technology, pharmaceuticals, and insurance, and often counsels pro bono clients on corporate governance matters, including compliance with the New York Not-for-Profit Corporation Law.

While in law school, Steven served as an associate editor of the Cardozo Journal of Conflict Resolution. He also gained experience as a summer associate with Hogan Lovells in 2011. Prior to law school, he worked as a paralegal in the Capital Markets group of another international law firm.

Education and admissions


J.D., Benjamin N. Cardozo School of Law, cum laude, 2012

B.A., Colgate University, 2007

Bar admissions and qualifications

New York

New Jersey

Representative experience

Colombian financial services firm Sura in connection with series of buyouts of JP Morgan interest, General Atlantic interest, and International Finance Corporation interest in Sura Asset Management.

Alcon in its acquisition of Transcend Medical, Inc., developer of technologies for the treatment of glaucoma.

Novartis in its US$665m acquisition of Selexys Pharmaceuticals, a developer of therapeutics to treat pain associated with blood/inflammatory disorders like sickle-cell disease.

Pamplona Capital in its acquisition of Charter Nex Holdings.

Google in its acquisition of Lift Labs.

HarperCollins in its acquisition of Harlequin Enterprises for C$455m, and subsequent integration matters.

A global insurer in the sale of its life insurance business involving, in the aggregate, gross insurance reserves of US$3.4bn.

A Bermuda-based reinsurance company in its acquisition of U.S. insurance companies.

One Rock Capital Partners in its acquisition of Kova International, Inc.

Frequently advises various U.S. and multinational corporate clients and financial institutions, including several Fortune 500 clients, in internal corporate reorganizations and restructurings.

Novartis in its acquisition of Encore Vision, focused on the development of a novel treatment in presbyopia.

Celgene Corporation in its acquisition of Impact Biomedicines, Inc. for up to US$7.0bn.

Loading data